Disc Medicine, Inc.

Disc Medicine, Inc.

Biotechnology • Healthcare • Watertown, MA, United States • IRON (NGM)

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.

617 674 9274 321 Arsenal Street, Watertown, MA 02472, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Disc Medicine (NASDAQ:IRON) Shares Down 9% After Insider Selling - MarketBeat
MarketBeat • Dec 19
How Disc Medicine rescued a discarded drug candidate - C&EN
C&EN • Nov 24
Disc Shares Slip Amid Report FDA’s Prasad is Skeptical of Bitopertin’s Efficacy - BioSpace
BioSpace • Dec 22
What Makes Disc Medicine, Inc. (IRON) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Yahoo Finance • Oct 27
WilmerHale Advises Underwriters in $287.5 Million Public Offering of Disc Medicine - WilmerHale
WilmerHale • Oct 30

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Disc Medicine, Inc. had layoffs?
No layoff events have been recorded for Disc Medicine, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Disc Medicine, Inc. have?
Disc Medicine, Inc. has approximately 142 employees.
What industry is Disc Medicine, Inc. in?
Disc Medicine, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Disc Medicine, Inc. a publicly traded company?
Yes, Disc Medicine, Inc. is publicly traded under the ticker symbol IRON on the NGM. The company has a market capitalization of approximately $2.96 billion.
Where is Disc Medicine, Inc. headquartered?
Disc Medicine, Inc. is headquartered in Watertown, MA, United States at 321 Arsenal Street, Watertown, MA 02472, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.